I doubt your prediction will come to fruition. The valuation of this company is already over AUD $2 billion, and looking at the EBITDA and other products they currently have (or that are in the pipeline), I think any FDA approval is already almost priced in.
- Forums
- ASX - By Stock
- Post-FDA approval - example gains of up to 1100% post-approval
I doubt your prediction will come to fruition. The valuation of...
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.255B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.07 | $7.316M | 6.647M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 11059 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 104229 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 24842 | 1.070 |
23 | 181485 | 1.065 |
20 | 267533 | 1.060 |
14 | 163174 | 1.055 |
19 | 697836 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 126205 | 21 |
1.080 | 126420 | 16 |
1.085 | 200470 | 14 |
1.090 | 53365 | 6 |
1.095 | 35751 | 4 |
Last trade - 15.38pm 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |